Survival outcomes after extensive cytoreductive surgery and selective neoadjuvant chemotherapy according to institutional criteria in bulky stage IIIC and IV epithelial ovarian cancer

Author:

Lim Myong Cheol1234ORCID,Yoo Heong Jong25,Song Yong Jung26ORCID,Seo Sang-Soo2,Kang Sokbom724ORCID,Kim Sun Ho2,Yoo Chong Woo2,Park Sang-Yoon82ORCID

Affiliation:

1. Cancer Healthcare Research Branch, Research Institute and Hospital, National Cancer Center, Goyang, Korea.

2. Center for Uterine Cancer, Research Institute and Hospital, National Cancer Center, Goyang, Korea.

3. Center for Clinical Trials, Research Institute and Hospital, National Cancer Center, Goyang, Korea.

4. Department of Cancer Control and Population Health, Graduate School of Cancer Science and Policy, National Cancer Center, Goyang, Korea.

5. Department of Obstetrics and Gynecology, Chungnam National University Hospital, Chungnam, Korea.

6. Department of Obstetrics and Gynecology, Pusan National University Yangsan Hospital, Yangsan, Korea.

7. Precision Medicine Branch, Research Institute and Hospital, National Cancer Center, Goyang, Korea.

8. Common Cancer Branch, Research Institute and Hospital, National Cancer Center, Goyang, Korea.

Publisher

Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology and Colposcopy

Subject

Obstetrics and Gynecology,Oncology,General Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3